Results 101 to 110 of about 98,415 (200)

Glucagon-like peptide-1 receptor (GLP-1 receptor) [PDF]

Science-Business eXchange, 2008
openaire   +1 more source

Survodutide - Novel Anti Obesity Drug

JK Science
Survodutide (BI 456906) is a novel, dual agonist of glucagon and glucagon-like peptide-1 (GLP-1) receptors developed as a once-weekly subcutaneous injection for the management of obesity.
Irtiqa Ayani Rathore, Sana Malik, Amarjeet Singh, Vishal R Tandon, Annil Mahajan   +4 more
doaj  

Distribution of glucagon-like peptide 1 receptor and insulin in phaeochromocytomas. [PDF]

Endocr Connect
Følling I, Selle ML, Nilsen HR, Wennerström AB, Nilsen HL, Eide TJ.   +5 more
europepmc   +1 more source

Glucagon-like Peptide-1 Receptor Agonists in Liver Transplant Recipients: A Retrospective Cohort Study. [PDF]

Transplant Direct
Sheashaa H, Ibrahim R, Elshaer A, Pham HN, Mouhaffel R, Habib E, Abdelnabi M, Farina JM, Lester SJ, Simper D, Alsidawi S, Steidley ED, Aqel BA, Barnhill M, Kim WR, Ayoub C, Arsanjani R.   +16 more
europepmc   +1 more source

Pneumatosis intestinalis in a patient treated with a glucagon-like peptide-1 receptor agonist and prednisone. [PDF]

JCEM Case Rep
Sutton S, Ferguson Q, Gimpelevich R, Hemadeh O.   +3 more
europepmc   +1 more source

History of glucagon-like peptide-1 receptor agonists

Pharmacological Research
Radwan Darwish, Ghena Abu-Sharia, Alexandra E. Butler   +2 more
doaj   +1 more source

Should glucagon‐like peptide‐1 receptor agonist treatment be withheld in preoperative management?

Journal of Diabetes, 2023
Zachary Bloomgarden
doaj   +1 more source

Potential Antiarrhythmic Mechanisms of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1RAs). [PDF]

Drug Des Devel Ther
Li J, Fu K, Zhao J, Zou Y, Li L, Huang Q, Long L, Ou X, Lei M, Zhang C, Tan X, Chen T.   +11 more
europepmc   +1 more source

Corrigendum to: The Short and Sweet on Sodium-Glucose Cotransporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure. [PDF]

US Cardiol
Batista JL, Makuvire T, Davis JD, Carbone S.   +3 more
europepmc   +1 more source

Glucagon-like Peptide-1 Receptor Agonists and Platelet Function: Potential Benefits Beyond Glycemic Control. [PDF]

Pharmaceuticals (Basel)
Xanthopoulou M, Evangelidis P, Poulis D, Gavriilaki E, Kotsiou N, Antza C, Kotsis V, Doxani C, Mprotsis T, Zintzaras E, Anyfanti P.   +10 more
europepmc   +1 more source